Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cytotherapy

Showing results (931-940 of 2,791) with videos related to

Pageof 280
Sort By:
Cytotherapy|July 18, 2016
Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21Morten Hansen, Özcan Met, Niels Bent Larsen, et al.
Cytotherapy|July 19, 2016
Autologous mesenchymal stromal cells as a therapeutic in ALS and epilepsy patients: Treatment modalities and ex vivo neural differentiationAntos Shakhbazau, Michael Potapnev
Cytotherapy|June 3, 2015
Early neuroprotective effect with lack of long-term cell replacement effect on experimental stroke after intra-arterial transplantation of adipose-derived mesenchymal stromal cellsSeung-Hun Oh, Chunggab Choi, Da-Jeong Chang, et al.
Cytotherapy|June 15, 2015
Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirusVerena Pfirrmann, Sarah Oelsner, Eva Rettinger, et al.
Cytotherapy|June 4, 2015
Characterization of the Pall Celeris system as a point-of-care device for therapeutic angiogenesisGabriella Spaltro, Stefania Straino, Elisa Gambini, et al.
Cytotherapy|July 13, 2015
Heterogeneity of in vitro-cultured CD34+ cells isolated from peripheral bloodChristine Jobin, Marc Cloutier, Carl Simard, et al.
Cytotherapy|July 17, 2016
In vitro cytokine licensing induces persistent permissive chromatin at the Indoleamine 2,3-dioxygenase promoterYazmin I Rovira Gonzalez, Patrick J Lynch, Elaine E Thompson, et al.
Cytotherapy|April 19, 2020
Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemiaRajeswaran Mani, Girish Rajgolikar, Jessica Nunes, et al.
Cytotherapy|April 19, 2020
Identification of prognostic factors for γδT cell immunotherapy in patients with solid tumorRishu Takimoto, Tomoharu Miyashita, Eishiro Mizukoshi, et al.
Cytotherapy|April 13, 2020
Evaluation of serum-free media formulations in feeder cell-stimulated expansion of natural killer cellsJena E Moseman, Jennifer A Foltz, Kinnari Sorathia, et al.
Pageof 280

Showing results (931-940 of 2,791) with videos related to

Sort By:
Pageof 280
Cytotherapy|July 18, 2016
Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21Morten Hansen, Özcan Met, Niels Bent Larsen, et al.
Cytotherapy|July 19, 2016
Autologous mesenchymal stromal cells as a therapeutic in ALS and epilepsy patients: Treatment modalities and ex vivo neural differentiationAntos Shakhbazau, Michael Potapnev
Cytotherapy|June 3, 2015
Early neuroprotective effect with lack of long-term cell replacement effect on experimental stroke after intra-arterial transplantation of adipose-derived mesenchymal stromal cellsSeung-Hun Oh, Chunggab Choi, Da-Jeong Chang, et al.
Cytotherapy|June 15, 2015
Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirusVerena Pfirrmann, Sarah Oelsner, Eva Rettinger, et al.
Cytotherapy|June 4, 2015
Characterization of the Pall Celeris system as a point-of-care device for therapeutic angiogenesisGabriella Spaltro, Stefania Straino, Elisa Gambini, et al.
Cytotherapy|July 13, 2015
Heterogeneity of in vitro-cultured CD34+ cells isolated from peripheral bloodChristine Jobin, Marc Cloutier, Carl Simard, et al.
Cytotherapy|July 17, 2016
In vitro cytokine licensing induces persistent permissive chromatin at the Indoleamine 2,3-dioxygenase promoterYazmin I Rovira Gonzalez, Patrick J Lynch, Elaine E Thompson, et al.
Cytotherapy|April 19, 2020
Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemiaRajeswaran Mani, Girish Rajgolikar, Jessica Nunes, et al.
Cytotherapy|April 19, 2020
Identification of prognostic factors for γδT cell immunotherapy in patients with solid tumorRishu Takimoto, Tomoharu Miyashita, Eishiro Mizukoshi, et al.
Cytotherapy|April 13, 2020
Evaluation of serum-free media formulations in feeder cell-stimulated expansion of natural killer cellsJena E Moseman, Jennifer A Foltz, Kinnari Sorathia, et al.
Pageof 280